Form 8-K - Current report:
SEC Accession No. 0000921895-21-001523
Filing Date
2021-05-28
Accepted
2021-05-28 16:15:40
Documents
2
Period of Report
2021-05-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8k12566003_05282021.htm 8-K 16361
2 ex101to8k12566003_05282021.htm EX-10.1 59288
  Complete submission text file 0000921895-21-001523.txt   77066
Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617-514-7149
Summit Therapeutics Inc. (Filer) CIK: 0001599298 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36866 | Film No.: 21980373
SIC: 2834 Pharmaceutical Preparations